Clover Health Investments (CLOV) Reports In-Line Q4 EPS ; Offers Guidance

Clover Health Investments (NASDAQ: CLOV) reported Q4 EPS of ($0.10), in-line with the analyst estimate of ($0.10). Revenue for the quarter came in at $487.2 million versus the consensus estimate of $467.06 million.

GUIDANCE:

Clover Health Investments sees FY 2026 revenue of $2.81-2.92 billion, versus the consensus of $2.74 billion.

For earnings history and earnings-related data on Clover Health Investments (CLOV) click here.

You May Also Be Interested In

• Needham Starts Red Violet (RDVT) at Buy, 'offers the leading Cloud identity intelligence platform in the market today'
• Citi raises Atlassian price target to $225, maintains Buy rating
• Science Applications Int'l (SAIC) Tops Q2 EPS by 70c